4.6 Article

Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Jing-Houng Wang et al.

Summary: Atezolizumab plus bevacizumab has been approved as the first-line treatment for unresectable hepatocellular carcinoma. This study examined the efficacy and safety of this treatment in real-world clinical practice and found that it is effective and well-tolerated. In addition, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were identified as independent prognostic factors for progression-free survival (PFS).

CANCERS (2022)

Article Oncology

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

Kosei Kubota et al.

Summary: This study evaluated the utility of inflammation-based prognostic scores (IBPS) and systemic immune-inflammation index (SII) in the treatment of oral cancer patients. The results showed that higher pre-treatment PNI was associated with better overall survival (OS), while lower pre-treatment PNI and higher treatment SII were associated with poorer disease-free survival (DFS).

BMC CANCER (2022)

Article Oncology

The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment

Bong Kyung Bae et al.

Summary: This retrospective study evaluated the significance of systemic inflammatory markers (SIMs) in intrahepatic recurrence (IHR) of early-stage hepatocellular carcinoma (HCC) after curative treatment. The study found that SIMs were significantly associated with the prognosis of early-stage HCC patients who received initial curative treatment. The prognostic significances of SIMs were consistent for IHR-free survival, early and late IHR, and overall survival.

CANCERS (2022)

Article Nutrition & Dietetics

Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors

Hao Sun et al.

Summary: The prognostic nutrition index (PNI) can be used as a biomarker for identifying gastric cancer patients who may be sensitive to immune checkpoint inhibitors (ICIs), according to a retrospective study. This study found that patients with lower PNI had poorer progression-free survival and overall survival, particularly in those receiving ICIs.

FRONTIERS IN NUTRITION (2022)

Article Oncology

Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study

Tai Xu et al.

Summary: This study aimed to investigate the prognostic impact of prognostic nutritional index (PNI), systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) on breast cancer patients. The results showed that high PNI was associated with longer disease-free survival (DFS), indicating the importance of nutritional status and systemic immune function in patient prognosis.

BMC CANCER (2022)

Article Gastroenterology & Hepatology

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC

Dong Wang et al.

Summary: This study found that PNI and SII could be important prognostic parameters for HCC patients who underwent hepatectomy.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Oncology

Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer

Bulent Demirelli et al.

Summary: In this study, mGPS, PNI, and ECOG score were identified as independent indicators for shorter survival in metastatic gastric cancer patients. These indices, based on serum CRP, albumin levels, and complete blood counts, could be cost-effective, practical, and beneficial for routine clinical use in predicting survival outcomes.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)

Article Medicine, General & Internal

Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma

Hikmet Akkiz et al.

Summary: The serum levels of inflammation markers CRP, albumin, and ESR are associated with survival in HCC patients. Combinations of these markers show significant differences in survival, maximum tumor diameter, and percentage of patients with portal vein thrombosis in patients with both small and large size HCCs.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Article Oncology

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer

Emne Ali Abdallah et al.

Summary: The study investigated the importance of CTCs, CTM, PLR, and NLR in non-metastatic colon cancer progression, revealing that CTCs and PLR analysis may be clinically useful for colon cancer management and risk stratification. High PLR levels were associated with high-risk cancer stages, while NLR was not significantly linked to disease stage or recurrence.

TRANSLATIONAL ONCOLOGY (2021)

Article Oncology

Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma

Jie He et al.

Summary: This study found that PNI could serve as a reliable prognostic indicator in DLBCL patients, with low PNI being an independent risk factor for PFS and potentially predicting inferior OS. The novel prognostic index, NPI, formed by combining PNI with other significant prognostic factors, was more accurate in predicting worse PFS compared to NCCN-IPI and had a similar effect on predicting OS.

LEUKEMIA RESEARCH (2021)

Article Oncology

Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus

Chen Wang et al.

Summary: This study revealed that pretreatment NLR and PLR can serve as independent predictors for patients with locally advanced esophageal squamous cell carcinoma (ESCC) located in the middle or upper esophagus, helping to guide the choice between radical surgery or definitive chemoradiotherapy (dCRT) and being associated with prognosis. Patients with low NLR tend to have better survival outcomes when undergoing surgery.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Oncology

Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients

Yibiao Chen et al.

Summary: The study found that the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio can predict the survival of nasopharyngeal carcinoma patients.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Oncology

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

Seri Hong et al.

Summary: The study presents national cancer statistics and trends in Korea for 2018, covering incidence, mortality, survival, and prevalence rates. Overall, cancer incidence rates increased annually by 3.3% from 1999 to 2012, then decreased by 5.4% annually from 2012 to 2015, followed by insignificant changes. Meanwhile, cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years.

CANCER RESEARCH AND TREATMENT (2021)

Article Medicine, General & Internal

Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer

Cinthia Minatel Riguetto et al.

Summary: The study focused on examining the relationships of NLR, PLR, and MLR with clinicopathological characteristics of patients with differentiated thyroid cancer. PLR was higher in patients with distant metastasis, while MLR was associated with active disease. Cut-off values of NLR, PLR, and MLR were able to differentiate distant metastasis from lymph node metastasis with good sensitivity and accuracy.

CLINICS (2021)

Review Oncology

Clinical applications of proton and carbon ion therapy

Tilmann Rackwitz et al.

SEMINARS IN ONCOLOGY (2019)

Review Medicine, General & Internal

Nutrition in Cancer Patients

Paula Ravasco

JOURNAL OF CLINICAL MEDICINE (2019)

Review Physics, Multidisciplinary

Machine learning and the physical sciences

Giuseppe Carleo et al.

REVIEWS OF MODERN PHYSICS (2019)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

The future of image-guided radiotherapy-is image everything?

David J. Noble et al.

BRITISH JOURNAL OF RADIOLOGY (2018)

Article Oncology

Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009

Stephanie C. Melkonian et al.

CANCER CAUSES & CONTROL (2018)

Review Medical Laboratory Technology

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis

Bo Li et al.

CLINICA CHIMICA ACTA (2018)

Review Gastroenterology & Hepatology

Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies

Po-Hong Liu et al.

SEMINARS IN LIVER DISEASE (2018)

Review Immunology

The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure

Evangelos Triantafyllou et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Urology & Nephrology

Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy

Tanja Langsenlehner et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)

Article Otorhinolaryngology

Impact of Distant Metastasis in Patients with Cervical Lymph Node Metastases from Cancer of an Unknown Primary Site

Ralph M. W. Rödel et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2014)

Editorial Material Oncology

Platelets and Tumor Cells: A New Form of Border Control

Ben Z. Stanger et al.

CANCER CELL (2013)

Article Oncology

Predictors of early distant metastasis in women with breast cancer

Erick Sta. Rosa Mendoza et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)

Article Dentistry, Oral Surgery & Medicine

Risk Factors for Distant Metastasis in Squamous Cell Carcinoma of the Oral Cavity

Satoshi Sumioka et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2013)

Review Immunology

Protumor and antitumor functions of neutrophil granulocytes

Sven Brandau et al.

SEMINARS IN IMMUNOPATHOLOGY (2013)

Editorial Material Oncology

Progress with Intensity-modulated Radiotherapy Implementation in the UK

W. P. M. Mayles et al.

CLINICAL ONCOLOGY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Oncology

Dual Roles for Immunity in Gastrointestinal Cancers

Cristina Ferrone et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Review Oncology

Cancer related inflammation: The macrophage connection

Antonio Sica et al.

CANCER LETTERS (2008)

Review Multidisciplinary Sciences

Cancer-related inflammation

Alberto Mantovani et al.

NATURE (2008)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)